Human Papillomavirus Type 16 E6 and E7 Cause Polyploidy in Human Keratinocytes and Up-Regulation of G2-M-Phase Proteins

Cancer Research

Volumn 64, Issue 4, 2004, Pages 1299-1306

  Patel, Daksha ^a   Incassati, Angela ^a   Wang, Nancy ^a   McCance, Dennis J ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA A KINASE; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE 1; POLO LIKE KINASE 1; PROTEIN E6; PROTEIN E7; PROTEIN NEK2; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE G2 PHASE; CENTROSOME; CHROMOSOME SEGREGATION; CONTROLLED STUDY; GENE CONTROL; GENETIC STABILITY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; KERATINOCYTE; MITOSIS; MITOSIS SPINDLE; POLYPLOIDY; PRIORITY JOURNAL; PROTEIN FUNCTION; UPREGULATION; VIRUS STRAIN; WART VIRUS;

CELL CYCLE PROTEINS; CELL LINE; G2 PHASE; GENE EXPRESSION REGULATION; HUMANS; KERATINOCYTES; MITOSIS; NOCODAZOLE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS, VIRAL; POLYPLOIDY; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 1242338787     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-2917     Document Type: Article

References (52)

1. Boshart, M., Gissmann, L., Ikenberg, H., Kleinheinz, A., Scheurlen, W., and zur Hausen, H. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J., 3: 1151-1157, 1984.
2. Durst, M., Gissmann, L., Ikenberg, H., and zur Hausen, H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc. Natl. Acad. Sci. USA, 80: 3812-3815, 1983.
3. McCance, D. J., Campion, M. J., Clarkson, P. K., Chesters, P. M., Jenkins, D., and Singer, A. Prevalence of human papillomavirus type 16 DNA sequences in cervical intraepithelial neoplasia and invasive carcinoma of the cervix. Br. J. Obstet. Gynaecol., 92: 1101-1105, 1985.
4. Manos, M. M., Kinney, W. K., Hurley, L. O., Sherman, M. E., Sheih-Ngai, J., Kurman, R. J., Ransley, J. E., Fetterman, B. J., Hartinger, J. S., McIntosh, K. M., Pawlick, G. F., and Hiatt, R. A. Identifying women with cervical neoplasia. Using human papillomavirus DNA testing for equivocal Papanicolou results. J. Am. Med. Assoc., 281: 1605-1610, 1999.
5. Halbert, C. L., Demers, G. W., and Galloway, D. A. The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J. Virol., 66: 2125-2134, 1992.
6. Munger, K., Phelps, W. C., Bubb, V., Howley, P. M., and Schlegel, R. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol., 63: 4417-4421, 1989.
7. Hudson, J. B., Bedell, M. A., McCance, D. J., and Laiminis, L. A. Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18. J. Virol., 64: 519-526, 1990.
8. Huang, P. S., Patrick, D. R., Edwards, G., Goodhart, P. J., Huber, H. E., Miles, L., Garsky, V. M., Oliff, A., and Heimbrook, D. C. Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein. Mol. Cell. Biol., 13: 953-960, 1993.
9. Patrick, D. R., Oliff, A., and Heimbrook, D. C. Identification of a novel retinoblastoma gene product binding site on human papillomavirus type 16 E7 protein. J. Biol. Chem., 269: 6842-6850, 1994.
10. Dyson, N. The regulation of E2F by pRB-family proteins. Genes Dev., 12: 2245-2262, 1998.
11. Huibregtse, J. M., Scheffner, M., and Howley, P. M. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J., 10: 4129-4135, 1991.
12. Dalal, S., Gao, Q., Androphy, E. J., and Band, V. Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells. J. Vitol., 70: 683-688, 1996.
13. Scheffner, M., Huibregtse, J. M., Vierstra, R. D., and Howley, P. M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell, 75: 495-505, 1993.
14. Borel, F., Lohez, O. D., Lacroix, F. B., and Margolis, R. L. Multiple centrosomes arise from tetraploidy checkpoint failure and mitotic centrosome clusters in p53 and RB pocket protein-compromised cells. Proc. Natl. Acad. Sci. USA, 99: 9819-9824, 2002.
15. 1 arrest. Cancer Res., 58: 396-401, 1998.
16. Banin, S., Moyal, L., Shieh, S., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., and Ziv, Y. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science (Wash. DC), 281: 1674-1677, 1998.
17. Canman, C. E., Lim, D. S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., and Siliciano, J. D. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science (Wash. DC), 281: 1677-1679, 1998.
18. McMurray, H., and McCance, D. Human papillomavirus type 16 E6 activates TERT gene transcription through induction of c-myc and release of USF-mediated repression. J. Virol., 77: 9852-9861, 2003.
19. Brehm, A., Nielsen, S. J., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J., and Kouzarides, T. The E7 protein associates with Mi2 and histone deacetylase activity to promote cell growth. EMBO J., 18: 2449-2458, 1999.
20. Rajagopalan, H., Nowak, M. A., Vogelstein, B., and Lengauer, C. Opinion: the significance of unstable chromosomes in colorectal cancer. Nat. Rev. Cancer, 3: 695-701, 2003.
21. McCance, D. J., Kopan, R., Fuchs, E., and Laimins, L. A. Human papillomavirus type 16 alters human epithelial cell differentiation in vitro. Proc. Natl. Acad. Sci. USA, 85: 7169-7173, 1988.
22. Thomas, J. T., and Laimins, L. A. Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint. J. Virol., 72: 1131-1137, 1998.
23. Duensing, S., and Munger, K. The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. Cancer Res., 62: 7075-7082, 2002.
24. Duensing, S., Duensing, A., Flores, E. R., Do, A., Lambert, P. F., and Munger, K. Centrosome abnormalities and genomic instability by episomal expression of human papillomavirus type 16 in raft cultures of human keratinocytes. J. Virol., 75: 7712-7716, 2001.
25. Donaldson, M. M., Tavares, A. A., Hagan, I. M., Nigg, E. A., and Glover, D. M. The mitotic roles of Polo-like kinase. J. Cell Sci., 114: 2357-2358, 2001.
26. Dai, W., Wang, Q., and Traganos, K. Polo-like kinases and centrosome regulation. Oncogene, 21: 6195-6200, 2002.
27. Morgenstern, J. P., and Land, H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res., 18: 3587-3596, 1990.
28. Jewers, R. J., Hildebrandt, P., Ludlow, J. W., Kell, B., and McCance, D. J. Regions of human papillomavirus type 16 E7 oncoprotein required for immortalization of human keratinocytes. J. Virol., 66: 1329-1335, 1992.
29. Nguyen, D. X., Westbrook, T. F., and McCance, D. J. HPV-16 E7 maintains elevated levels of the cdc25A tyrosine phosphatase during deregulation of cell cycle arrest. J. Virol., 76: 619-632, 2002.
30. Liu, Y., Chen, J. J., Gao, Q., Dalal, S., Hong, Y., Mansur, C. P., Band, V., and Androphy, E. J. Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells. J. Virol., 73: 7297-7307, 1999.
31. Crook, T., Tidy, J. A., and Vousden, K. H. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell, 67: 547-556, 1991.
32. Tusher, V. G., Tibshirani, R., and Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA, 98: 5116-5121, 2001.
33. Chen, J. J., Hong, Y., Rustamzadeh, E., Baleja, J. D., and Androphy, E. J. Identification of an α helical motif sufficient for association with papillomavirus E6. J. Biol. Chem., 273: 13537-13544, 1998.
34. Gonzalez, S. L., Stremlau, M., He, X., Basile, J. R., and Munger, K. Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7. J. Virol., 75: 7583-7591, 2001.
35. Demers, G. W., Espling, E., Harry, J. B., Etscheid, B. G., and Galloway, D. A. Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for transformation. J. Virol., 70: 6862-6869, 1996.
36. Davies, R., Hicks, R., Crook, T., Morris, J., and Vousden, K. Human papillomavirus type 16 E7 associates with a histone HI kinase and with p107 through sequences necessary for transformation. J. Virol., 67: 2521-2528, 1993.
37. Zhao, J., Kennedy, B. K., Lawrence, B. D., Barbie, D. A., Matera, A. G., Fletcher, J. A., and Harlow, E. NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. Genes Dev., 14: 2283-2297, 2000.
38. Pines, J., and Rieder, C. L. Re-staging mitosis: a contemporary view of mitotic progression. Nat. Cell Biol., 3: E3-E6, 2001.
39. Meraldi, P., Honda, R., and Nigg, E. A. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells. EMBO J., 21: 483-492, 2002.
40. Anand, S., Penrhyn-Lowe, S., and Venkitaraman, A. R. AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. Cancer Cell, 3: 51-62, 2003.
41. Glover, D. M., Hagan, I. M., and Tavares, A. A. M. Polo-like kinases: a team that plays throughout mitosis. Genes Dev., 12: 3777-3787, 1998.
42. Nigg, E. A. Polo-like kinases: positive regulators of cell division from start to finish. Curr. Opin. Cell Biol., 10: 776-783, 1998.
43. Peters, J-M. The anaphase-promoting complex: Proteolysis in mitosis and beyond. Mol. Cell, 9: 931-943, 2002.
44. Heselmeyer, K., Schrock, E., du Manoir, S., Blegen, H., Shah, K., Steinbeck, R., Auer, G., and Ried, T. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc. Natl. Acad. Sci. USA, 93: 479-484, 1996.
45. Furuta, R., Hirai, Y., Katase, K., Tate, S., Kawaguchi, T., Akiyama, F., Kato, Y., Kumada, K., Iwasaka, T., Yaegashi, N., Kanazawa, K., Yoshikawa, H., and Kitagawa, T. Ectopic chromosome around centrosome in metaphase cells as a marker of high-risk human papillomavirus-associated cervical intraepithelial neoplasias. Int. J. Cancer, 106: 167-171, 2003.
46. Duensing, S., and Munger, K. Human papillomaviruses and centrosome duplication errors: modeling the origins of genomic instability. Oncogene, 21: 6241-6248, 2002.
47. Fu, B., Quintero, J., and Baker, C. C. Keratinocyte growth conditions modulate telomerase expression, senescence, and immortalization by human papillomavirus type 16 E6 and E7 oncogenes. Cancer Res., 63: 7815-7824, 2003.
48. Bruce, J. L., Hurford, R. K., Jr., Classon, M., Koh, J., and Dyson, N. Requirements for cell cycle arrest by p16INK4a. Mol. Cell, 6: 737-742, 2000.
49. 2-M checkpoints. Genes Dev., 16: 245-256, 2002.
50. Nigg, E. A. Mitotic kinases as regulators of cell division and its checkpoints. Nat. Rev. Mol. Cell Biol., 2: 21-32, 2001.
51. Bischoff, J. R., Anderson, L., Zhu, Y., Mossie, K., Ng, L., Souza, B., Schryver, B., Flanagan, P., Clairvoyant, F., Ginther, C., Chan, C. S., Novotny, M., Slamon, D. J., and Plowman, G. D. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J., 17: 3052-3065, 1998.
52. Zhou, H., Kuang, J., Zhong, L., Kuo, W. L., Gray, J. W., Sahin, A., Brinkley, B. R., and Sen, S. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat. Genet., 20: 189-193, 1998.